Zephyr Medical Enterprises Encino, CA - 91316

Zephyr Medical Enterprises is categorized under Educational Cooperative Organizations in Encino, CA and active since 1989.

Zephyr Medical Enterprises was established in 1989, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Educational Cooperative Organizations business, which does work in the B2C market, and is classified as a Educational Cooperative Organizations, under code number 611699 by the NAICS.

If you are seeking more information, feel free to contact Melvin Schapiro at the company’s single location by writing to 5311 Aldea Avenue, Encino, California CA 91316 or by phoning (818) 986-8098. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Zephyr Medical Enterprises
Contact Person: Melvin Schapiro
Address: 5311 Aldea Avenue, Encino, California 91316
Phone Number: (818) 986-8098
Annual Revenue (USD): $100.000 to $499.999
Founded: 1989
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Educational Cooperative Organizations
SIC Code: 8299
NAICS Code: 611699
Share This Business:

Zephyr Medical Enterprises was started in 1989 to provide professional Educational Cooperative Organizations under the SIC code 8299 and NAICS code 611699. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Melvin Schapiro for inquiries that concern Zephyr Medical Enterprises by calling the company number (818) 986-8098, as your correspondence is most welcome. Additionally, the physical location of the single location of Zephyr Medical Enterprises can be found at the coordinates as well as the street address 5311 Aldea Avenue in Encino, California 91316.

For its online presence, you may visit Zephyr Medical Enterprises’s website at and engage with its social media outlets through on Twitter and on Facebook.